Skip to main content
logo
Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
8.11
-0.41 (-4.81%)
At close: Mar 11, 2026, 4:00 PM EDT
8.10
-0.01 (-0.12%)
After-hours: Mar 11, 2026, 5:03 PM EDT

Kazia Therapeutics Balance Sheet

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024
Period Ending
Jun '25 Jun '24
Cash & Equivalents
4.351.66
Cash & Short-Term Investments
4.351.66
Cash Growth
162.22%-
Accounts Receivable
0.13.9
Other Current Assets
0.490.59
Total Current Assets
4.936.15
Net Property, Plant & Equipment
1.1315.44
Other Intangible Assets
1.0915.4
Other Long-Term Assets
0.040.04
Total Assets
6.0621.59
Accounts Payable
10.1215.07
Accrued Expenses
0.390.37
Short-Term Debt
0.40.63
Other Current Liabilities
3.159.73
Total Current Liabilities
14.0525.8
Other Long-Term Liabilities
0.315.81
Total Long-Term Liabilities
0.315.81
Total Liabilities
14.3631.6
Common Stock
123.05101.64
Additional Paid-in Capital
0.38-
Accumulated Other Comprehensive Income
3.13.48
Retained Earnings
-134.83-115.13
Shareholders' Equity
-8.3-10.02
Total Liabilities & Equity
6.0621.59
Total Debt
0.40.63
Net Cash (Debt)
3.951.02
Net Cash Growth
286.02%-
Net Cash Per Share
3.601.94
Book Value
-8.3-10.02
Book Value Per Share
-7.57-18.99
Tangible Book Value
-9.39-25.42
Tangible Book Value Per Share
-8.57-48.20
Updated Nov 7, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q